Ets1 was significantly activated by ERK1/2 in mutant K-ras stably transfected human adrenocortical cells

Y-F Chen1, S-J Shin, S-R Lin

  • 1MedicoGenomic Research Center, Kaohsiung, Taiwan.

DNA and Cell Biology
|February 9, 2005
PubMed

Insights

Mutant K-ras in adrenal tumors upregulates Ets1, a protein crucial for cell proliferation. This leads to increased expression of uPA, MMP-3, and prolactin, driving tumorigenesis.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Previous studies identified frequent K-ras gene mutations in human adrenal tumors.
  • Understanding the molecular mechanisms driving adrenal tumorigenesis is critical.

Purpose of the Study:

  • To investigate gene expression changes in adrenocortical cells with mutant K-ras.
  • To elucidate the role of Ets1 in K-ras-driven adrenal cell proliferation and tumorigenesis.

Main Methods:

  • DNA microarray analysis of mutant K-ras transfected adrenocortical cells.
  • Bioinformatic analysis using Matchminer, Gominer, DAVID, and Pathart.
  • Western blotting and membrane blotting to confirm protein phosphorylation and expression levels.

Main Results:

  • Mutant K-ras upregulated Ets1 expression, primarily linked to cell proliferation.
  • Ets1 activation, via ERK1/2 phosphorylation, led to increased expression of uPA, MMP-3, and prolactin.
  • Expression levels of prolactin, MMP-3, and uPA were significantly elevated (1.4-fold, 1.8-fold, and 2.1-fold, respectively) in mutant K-ras cells.

Conclusions:

  • A mechanism is proposed where mutant K-ras activates Ets1, promoting adrenocortical cell proliferation.
  • Ets1 plays a key role in the tumorigenesis pathway initiated by K-ras mutations in adrenal cells.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: